Tel:
Fax:
Email:
Creative Biolabs

NeuroMab™ Anti-OPN BBB Shuttle Antibody,Clone NR1374P

[CAT#: NRZP-1022-ZP2592]

Host Species:
Mouse; Chimeric; Humanized
Species Reactivity:
Human
Applications:
ELISA; Block; Inhib; In Vitro; In vivo

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

SPECIFIC INQUIRY

inquiry
Size:
Conjugation:
Endotoxin:
Purity:
Engineering:
Product Overview

Description

Brain uptake of therapeutic antibodies is severely limited by their size. To achieve enhanced BBB crossing, Creative Biolabs developed a BBB shuttle antibody platform by utilizing the endogenous macromolecule transportation pathway, known as receptor-mediated transcytosis (RMT). The engineered antibody-based carrier is believed to significantly to increase the macromolecule brain entry to combat CNS diseases.
Notes: The BBB antibody is made-to order and available in a customized format. Please don't hesitate contact us for more details.

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Mouse; Chimeric; Humanized

Clone Number

NR1374P

Applications

ELISA; Block; Inhib; In Vitro; In vivo

Relevant Diseases

Alzheimer's Disease; Neuroinflammation
Product Properties

Storage

Store at -20°C. Do not aliquot the antibody.

Research Use Only

For research use only
Target

Target

SPP1

Official Name

SPP1

Full Name

Secreted phosphoprotein 1

Alternative Names

BNSP;
Bone sialoprotein 1;
Bone sialoprotein I;
BSP I;
BSPI;
Early T lymphocyte activation 1;
ETA 1;
ETA1;
MGC110940;
Nephropontin;
OPN;
Osteopontin;
Product Pictures
Inhib

Fig.1 shows graphs depicting the inhibition of RGD-dependent and RGD-independent cell adhesion between nOPN and a9-transformed SW480 cell by the murine antibody 2K1.

Experimental result shows that the cell of S-113-6 antibody treatment significantly reduces than the ability of Mork group (PBS) and the cell migration of irrelevant antibody control group in the 48hrs.

Inhib

Fig.2 shows graphs depicting the suppression of OPN-induced cell migration by antibodies.

Experimental result shows that the cell of S-113-6 antibody treatment significantly reduces than the ability of Mork group (PBS) and the cell migration of irrelevant antibody control group in the 48hrs.

Inhib

Fig.3 shows graphs depicting the inhibition of RGD-dependent cell adhesion to OPN.

Experimental result shows that the cell of S-113-6 antibody treatment significantly reduces than the ability of Mork group (PBS) and the cell migration of irrelevant antibody control group in the 48hrs.

Publications

Publications (0)

gift-card

Related Products
For Research Use Only. Not For Clinical Use.
Product
Hot Products
Fill out this form for a quote Inquiry Form Send Inquiry
webinar
Inquiry Basket
compare

Send inquiry